US$ 25.79
semaglutide left out The Pros and Cons of for Weight Loss Some people are overdosing on
Description
P.EvansJ

The introduction of this new indication may have led to a broader user population, consequently resulting in a higher number of reported adverse reactions
Tirzepatide (Mounjaro/Zepbound) offers dual GLP-1 and GIP agonism, achieving approximately 20.9% weight loss

[1] [4] Wegovy should not be used during pregnancy or breastfeeding, and caution is needed when used with insulin or sulfonylureas due to hypoglycaemia risk

10.1007/s108s5795 [DOI] [PMC free article] [PubMed] [Google Scholar] Diamond M
